Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

GlobeNewswire

BOSTON, Oct. 24, 2026 -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the publication of results from the positive Phase 2/3 COMPANION-002 study of tovecimig in combination with paclitaxel in patients with previously treated, advanced biliary tract cancer (BTC) in the Journal of Clinical Oncology (JCO). The results are also being presented today by Nilofer S. Azad, M.D., Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain. The full publication is available via open access at https://ascopubs.org/toc/jco/0/ja.

  1. HealthcareKFSH erweitert den Zugang zur Notfallversorgung durch virtuelle Versorgung und die Koordination durch FachärzteDas King Faisal Specialist Hospital and Research Centre (KFSH) erweitert den Zugang der Patienten zu Notfallkompetenz über die Grenzen seiner stationären Abteilungen hinaus. Dank des virtuellen Zugangs zur Notaufnahme und der Koordination durch Fachärzte können Patienten frühzeitig untersucht und an die am besten geeignete Versorgungsebene weitergeleitet werden.
  2. HealthcareKFSH élargit l’accès aux urgences grâce aux soins virtuels et à la coordination des spécialistesRIYAD, Arabie saoudite, 24 oct. 2026 -- Le King Faisal Specialist Hospital and Research Centre (KFSH) élargit l’accès des patients à l’expertise des services d’urgence au-delà de ses locaux. Son accès virtuel au service des urgences et la coordination des spécialistes permettent d’évaluer les patients rapidement et de les orienter vers le niveau de soins le plus approprié.
  3. HealthcareKFSH Extends Emergency Access Through Virtual Care and Specialist CoordinationKing Faisal Specialist Hospital and Research Centre (KFSH) is widening patients’ access to emergency expertise beyond its physical departments. Its virtual Emergency Department access and specialist coordination allow patients to be assessed early and directed to the most appropriate level of care.
  4. AirTripMaker Launches Comprehensive Business Class Flight Routes Guide from the USA to 15 Major International Destinations and RegionsAirTripMaker Launches Comprehensive Business Class Flight Routes Guide from the USA to 15 Major International Destinations and Regions
  5. Alkanes borrningar bekräftar och utvidgar guld-antimon-mineralsystemet vid Nagambie i VictoriaAlkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (”Alkane”) gläds över att kunna presentera de första prospekteringsresultaten från en så kallad earn-in-period, under vilken Alkane har åtagit sig att inledningsvis satsa totalt 12,5 miljoner dollar på prospektering och utvärdering för att under tre år förvärva en andel på 60 % i Nagambie-fastigheten, med rätt att öka andelen till 80 % genom ytterligare utgifter.1
  6. Government & policyCelcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026Median PFS was 21.5 months with the gedatolisib triplet and 11.5 months with the gedatolisib doublet versus 9.1 months with alpelisib + fulvestrant in patients who had no liver metastases